SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-23-000121
Filing Date
2023-02-08
Accepted
2023-02-08 09:53:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 VINCERX_PHARMA.txt SC 13G 21803
  Complete submission text file 0000769993-23-000121.txt   23622
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

IRS No.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Subject) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91457 | Film No.: 23597409
SIC: 2834 Pharmaceutical Preparations